Braidwell »

Tandem Diabetes Care shares owned by Braidwell

Quarter-by-quarter ownership of Tandem Diabetes Care shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Tandem Diabetes Care

Tip: Access up to 7 years of quarterly data

All positions including Tandem Diabetes Care held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tandem Diabetes Care by Braidwell

Quarter filed Position value Share count Share price at filing
2023-12-31 $67M 71M 0.95

More positions owned by Braidwell

Guardant Health Note 11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note 11/0 (Principal)
Neurocrine Biosciences (NBIX)
Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Nuvasive Note 0.375% 3/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Day One Biopharmaceuticals I (DAWN)
Irhythm Technologies (IRTC)
Argenx Se Sponsored Adr (ARGX)
Bridgebio Pharma Note 2.250% 2/0 (Principal)

View all positions for Braidwell

Top funds holding Tandem Diabetes Care

Tenor Capital Management
Braidwell
Highbridge Capital Management
Balyasny Asset Management
DLD Asset Management
Ofi Invest Asset Management
Palisade Capital Management
Worth Venture Partners
Citigroup
Calamos Advisors
Nomura Holdings

View all funds holding Tandem Diabetes Care